📷 Image: Wikimedia Commons / N509FZ
Health
NPPA Extends Knee‑Implant Price Cap Until Jan 15 2027
✍️ TripuraTimes.com
🗓 14 Nov 2026, 04:36 PM
👁 32
The National Pharmaceutical Pricing Authority has prolonged the ceiling price for knee‑implant devices to 15 January 2027.
The National Pharmaceutical Pricing Authority (NPPA) announced today that the price ceiling for knee‑implant devices will remain in force until 15 January 2027. The extension was issued through an official notification, reaffirming the regulator’s commitment to keep essential orthopedic implants affordable.
The decision follows a review of market dynamics and feedback from hospitals and patient groups, who warned that a lapse in the price cap could lead to a sharp rise in out‑of‑pocket expenses for knee‑replacement surgeries. By maintaining the ceiling, the NPPA aims to prevent price inflation and ensure wider access to the implants across public and private hospitals.
Manufacturers of knee‑implants will continue to sell their products at the capped rates stipulated in the earlier order, while any new pricing proposals will be subject to NPPA’s approval. Health experts say the move should help keep the cost of joint‑replacement procedures stable, especially for senior citizens and low‑income patients.
The original price‑cap deadline was set for 31 December 2025, but the regulator opted for a two‑year extension to provide certainty to both the supply chain and end‑users.
The decision follows a review of market dynamics and feedback from hospitals and patient groups, who warned that a lapse in the price cap could lead to a sharp rise in out‑of‑pocket expenses for knee‑replacement surgeries. By maintaining the ceiling, the NPPA aims to prevent price inflation and ensure wider access to the implants across public and private hospitals.
Manufacturers of knee‑implants will continue to sell their products at the capped rates stipulated in the earlier order, while any new pricing proposals will be subject to NPPA’s approval. Health experts say the move should help keep the cost of joint‑replacement procedures stable, especially for senior citizens and low‑income patients.
The original price‑cap deadline was set for 31 December 2025, but the regulator opted for a two‑year extension to provide certainty to both the supply chain and end‑users.